Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 391 across all filing types
Latest filing 2020-03-24 Declaration of Voting R…
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM). It details the voting outcomes for various agenda items, including financial statement approval, director and auditor appointments, and board remuneration. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-03-24 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's leadership, specifically the appointment of a new co-CEO (Representative Director). It details the 'before' and 'after' status of the board/management, the reason for the change, and the effective date. This aligns perfectly with the definition for Board/Management Information (MANG).
2020-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of an outside director (사외이사). This type of disclosure specifically concerns changes in the company's board composition, which falls under the 'Board/Management Information' category.
2020-03-24 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 98% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It explicitly states it is a 'Correction Report' (정정신고) for a previously filed document, detailing changes to share issuance amounts, payment dates, and third-party allocation details. In the context of Korean regulatory filings (DART), this is a formal disclosure of a capital change/financing event. Since it details the specific terms of a capital increase (share issuance), it falls under the 'Share Issue/Capital Change' category.
2020-03-24 Korean
[기재정정]경영권변경등에관한계약체결
Board/Management Information Classification · 98% confidence The document is a regulatory filing from a Korean company (Medifron) detailing a change in management control and a third-party capital increase (share issuance). It explicitly mentions '경영권 변경 등에 관한 계약 체결' (Execution of a contract regarding change of management control) and provides details on the acquirers, share amounts, and payment schedules. This falls under the category of M&A activity and capital structure changes, which is best classified as 'TAR' (M&A Activity) given the focus on the transfer of management control and ownership.
2020-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from a Korean company (Medifron) titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion, key financial data, and auditor information as required by regulatory standards. While it contains financial data, it is a summary disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report document. Given the structure and the nature of the disclosure, it fits best as a regulatory filing announcement. FY 2019
2020-03-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.